About One in Six Men With Grade Group 1 Prostate Cancer Has Intermediate-, High-Risk...
Prostate cancer-specific mortality rates 2.4 and 4.7 percent for unfavorable intermediate-risk and high-risk GG1
Larazotide May Speed Recovery in Children With Multisystem Inflammatory Syndrome
Faster resolution of GI symptoms, faster clearance of spike antigen, faster return to usual activities reported for children treated with larazotide
Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years
Cognitive functional therapy, with or without biofeedback, more effective than usual care for chronic disabling low back pain
CPAP Preferentially Improves Cardiovascular Outcomes in High-Risk OSA
Stronger differential effect for CPAP seen for those without excessive sleepiness, without increased blood pressure
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
Higher proportion of participants achieved HbA1c levels below 6.5 percent with canagliflozin versus placebo
Similar Impact on Mental Health Seen for Exposure to Physical, Verbal Abuse in Childhood
Exposure to childhood physical or verbal abuse similarly linked to lower mental well-being in adulthood
Clinical Guideline Updated for Management of Adult Rhinosinusitis
Watchful waiting extended as initial management strategy for all patients with uncomplicated acute bacterial rhinosinusitis
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
No significant increases seen in rate of hospital contacts for any of 29 adverse events in 28-day risk period after vaccination
3 Deaths, 67 People in NYC Diagnosed With Legionnaires’ Disease
